InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Discover the full record of transactions filed by Rothfuss Cristin. Officer active across 1 company, notably Sarepta Therapeutics, Inc.. Cumulatively, 11 disclosures have been published. History available since 26 November 2024. The latest transaction was disclosed on 4 September 2026 (Retenue fiscale). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
11 条申报中的 11 条
Cristin Rothfuss is a declarant linked to Sarepta Therapeutics, Inc., where the listed role is EVP, General Counsel. The record shows 10 filings in total, and across the 10 sampled filings the most frequent transaction nature is tax withholding, with a period running from 2024-11-29 to 2026-03-13 and buy and sell amounts shown as EUR 0.